Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Robin Parihar, Julie Dierksheide, Yan Hu, William E. Carson
Robin Parihar, Julie Dierksheide, Yan Hu, William E. Carson
View: Text | PDF
Article Oncology

IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

  • Text
  • PDF
Abstract

Research Article

Authors

Robin Parihar, Julie Dierksheide, Yan Hu, William E. Carson

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Both NK cells and T cells exhibit significant production of IFN-γ in res...
Both NK cells and T cells exhibit significant production of IFN-γ in response to Herceptin and IL-12 costimulation. The MDA-468 and SKBR3 cell lines were cultured with PBMCs within our in vitro coculture assay. Standard controls were also included. Brefeldin A (10 μg/ml) was included in all culture wells in order to halt protein trafficking from the Golgi. After 6 hours of culture, cells were harvested and labeled for surface expression of either CD56, CD3, CD20, or CD14 with PE-labeled mAb’s. Cells were then permeabilized, fixed, and stained for intracellular IFN-γ protein with an FITC-labeled mAb. Shown are representative dot plots of the PBMC population (vs. the SKBR3 cell line) stained for IFN-γ production within (a) CD56+ NK cells and (b) CD3+ T cells. The percentage of cells secreting IFN-γ along with the mean fluorescent intensity (MFI) is indicated within each plot. The fluorescent intensity of cells stained with isotype control Ab’s routinely fell within the first log (not shown).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts